Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
==================================================================================================================

* Rikke B Holmgaard
* Dmitriy Zamarin
* David H Munn
* Jedd D Wolchok
* James P Allison